Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLiontrust Asset Management Regulatory News (LIO)

Share Price Information for Liontrust Asset Management (LIO)

Share Price is delayed by 15 minutes
Get Live Data
301.00    -0.50 (-0.17%)
Bid:
311.50
Ask:
270.00
Spread: -41.50 (-13.323%)
Market Cap: £178.91m
LIO Live PriceLast checked at - London Stock Exchange

Intraday Liontrust Asset Management Share Chart

Response to statement by GAM Holding AG

24 Apr 2023 10:30

RNS Number : 2256X
Liontrust Asset Management PLC
24 April 2023
 

DISCLOSURE OF INSIDE INFORMATION ACCORDING TO ARTICLE 17 OF THE UK VERSION OF REGULATION (EU) NO. 596/2014 (WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWL) ACT 2018)

 

FOR IMMEDIATE RELEASE

 

LIONTRUST ASSET MANAGEMENT PLC

Response to statement by GAM Holding AG

 

Further to the announcement of 18 April 2023, Liontrust Asset Management Plc ("Liontrust", or the "Company"), the specialist independent fund management group, notes the announcement made today by GAM Holding AG ("GAM") that on conclusion of the commercial discussions, which includes discussions with Liontrust about a combination of the two firms, within their strategic review, a further update is expected on or prior to 4 May 2023.

 

There can be no certainty that this will lead to a formal offer in respect of the proposed acquisition of the entire issued share capital of GAM by Liontrust ("Proposed Acquisition"), nor as to the timing or terms of any such offer, and there can be no assurance that, even if agreement is reached, any such Proposed Acquisition would be completed.

 

A further announcement will be made as and when appropriate.

 

For further information please contact:

 

Teneo (Tel: 020 7353 4200, Email: liontrust@teneo.com)

Tom Murray or Stephanie Mackrell

 

Liontrust Asset Management Plc (Tel: 020 7412 1700, Website: liontrust.co.uk)

John Ions: Chief Executive

Vinay Abrol: Chief Financial Officer & Chief Operating Officer

Simon Hildrey: Chief Marketing Officer

David Boyle: Head of Corporate Development

 

Singer Capital Markets (Tel: 020 7496 3000)

Stephen Howard, Tom Salvesen, Justin McKeegan

 

Panmure Gordon (Tel: 020 7886 2500)

Corporate Broking: Stephen Jones

Corporate Advisory: Dominic Morley

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPEAPLLASSDEEA
Date   Source Headline
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20264:36 pmRNSForm 8.3 - MIND GYM PLC
4th Feb 20262:19 pmRNSForm 8.3 - KITWAVE GROUP PLC
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20263:23 pmRNSForm 8.3 - KITWAVE GROUP PLC
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20263:56 pmRNSForm 8.3 - KITWAVE GROUP PLC
2nd Feb 20267:05 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20263:22 pmRNSForm 8.3 -KITWAVE GROUP PLC
29th Jan 20263:19 pmRNSForm 8.3 - Auction Technology Group
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20262:45 pmRNSForm 8.3 - Oxford Biomedica Plc
28th Jan 20262:40 pmRNSForm 8.3 - Kitwave Group Plc
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20263:25 pmRNSForm 8.3 - Auction Technology Group Plc
26th Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20262:08 pmRNSForm 8.3 - Oxford Biomedica Plc
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20264:40 pmRNSForm 8.3 - Auction Technology Group PLC
14th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTrading Statement
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20263:17 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20263:29 pmRNSHolding(s) in Company
2nd Jan 202611:08 amRNSTotal Voting Rights
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20254:00 pmRNSDirector/PDMR Shareholding
19th Dec 20254:00 pmRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20255:44 pmRNSForm 8.3 - INSPECS GROUP PLC
12th Dec 20255:27 pmRNSForm 8.3 - INSPECS GROUP PLC
11th Dec 20251:42 pmRNSForm 8.3 - INSPECS GROUP PLC
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20253:03 pmRNSForm 8.3 - INSPECS GROUP PLC
10th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.